The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer-Reference-Cited by-同舟云学术

The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer

Published:2022-07-11 Issue:16 Volume:13 Page:2346-2354
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Kang Da Hyun¹^ORCID,Choi Seong‐woo¹,Sun Pureum²,Chung Chaeuk¹^ORCID,Park Dongil¹^ORCID,Lee Song‐I¹^ORCID,Koh Jeong Suk¹,Kim Yoonjoo¹^ORCID,Lee Jeong Eun¹^ORCID

Affiliation:

1. Department of Internal Medicine College of Medicine, Chungnam National University Daejeon South Korea

2. Research Institute for Medical Sciences College of Medicine, Chungnam National University Daejeon South Korea

Funder

Chungnam National University Hospital

Ministry of Science and Technology

National Research Foundation of Korea

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14568

Reference29 articles.

1. Global Epidemiology of Lung Cancer

2. Immunotherapy for Advanced Non–Small Cell Lung Cancer: A Decade of Progress

3. The blockade of immune checkpoints in cancer immunotherapy

4. Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non–Small Cell Lung Cancer

5. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between CD4⁺ T cells ATP levels and disease progression in patients with non‑small cell lung cancer;Oncology Letters;2024-06-12

2. The Potential of CD4+ T cells ATP level to indicate the Progression in NSCLC Patients;2023-12-13

3. Mechanism of Taxanes in the Treatment of Lung Cancer Based on Network Pharmacology and Molecular Docking;Current Issues in Molecular Biology;2023-08-07

4. Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids;Cells;2023-07-14

5. The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment;Frontiers in Immunology;2023-01-10